このエントリーをはてなブックマークに追加
ID 54512
JaLCDOI
FullText URL
Thumnail 70_4_317.pdf 1.88 MB
Author
Sakurai, Jun Center for Innovative Clinical Medicine, Okayama University Hospital
Matsui, Yusuke Department of Radiology, Okayama University Hospital
Hiraki, Takao Department of Radiology, Okayama University Hospital Kaken ID researchmap
Iguchi, Toshihiro Department of Radiology, Okayama University Hospital
Fujiwara, Hiroyasu Department of Radiology, Okayama University Hospital
Gobara, Hideo Department of Radiology, Okayama University Hospital
Mitsuhashi, Toshiharu Center for Innovative Clinical Medicine, Okayama University Hospital Kaken ID researchmap
Nagasaka, Takeshi Department of Gastroenterological Surgery Transplant and Surgical Oncology, Okayama University Hospital
Susumu Kanazawa, Susumu Kanazawa Department of Radiology, Okayama University Hospital Kaken ID publons
Abstract
The present single center prospective phase II clinical trial is designed to evaluate the efficacy and safety of percutaneous radiofrequency (RF) ablation for colorectal lung metastases. Patients who have colorectal lung metastases without extrapulmonary metastases are included in this study. The primary endpoint is 3-year overall survival (OS) after RF ablation. The secondary endpoints are the prevalence of adverse events within 4 weeks, local tumor progression rate, 1- and 5-year OS, cause-specific survival, and relapse-free survival. The recruitment of patients commenced in July 2014, and the enrolment of 45 patients is intended over the 3 years of study period.
Keywords
radiofrequency ablation
colorectal cancer
lung metastasis
Amo Type
Clinical Study Protocols
Published Date
2016-08
Publication Title
Acta Medica Okayama
Volume
volume70
Issue
issue4
Publisher
Okayama University Medical School
Start Page
317
End Page
321
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
英語
Copyright Holders
CopyrightⒸ 2016 by Okayama University Medical School
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT